INSP
Inspire Medical Systems, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+22/100
Last price
68.20
▼ 2.55 (3.60%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
71.23
Prev close
70.75
Day high
71.86
Day low
67.99
Volume
869.55K
Market cap
$1.97B
P/E (TTM)
15.02
52W range
38.91 – 147.03
Day trading desk
Gap from prior close
+0.68%
Prior close 70.75
VWAP
68.39
-0.28% from price
Relative volume
1.19×
Normal
Session range
5.69%
67.99 – 71.86
Position in range
5%
Near session low
ATR (14D)
3.74
5.48% of price
Prior day high
71.36
PDH
Prior day low
68.67
PDL
Bid / ask spread
—
Quote not published
Session volume
951.25K
Avg 798.63K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-6.81%
-8.8%
1M
+8.12%
+7.0%
3M
+38.34%
+33.8%
6M
+25.32%
+7.1%
YTD
-26.05%
-40.3%
1Y
-10.94%
-27.4%
3Y
-65.63%
-147.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on INSP open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+38.61K
Net buying
Buy transactions
19
53.61K shares
Sell transactions
5
15.00K shares
Net transactions
+24
Buys less sells
Sell : buy shares
0.3 : 1
Mixed
Insider-held shares
340.27K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 31, 26 | KELLY JASON P Chief Operating Officer |
STOCK | 6.35K | $0 | Direct |
| Aug 7, 26 | KELLY JASON P Officer |
SELL | 963 | $57.35K | Direct |
| Jul 20, 26 | CARREL MICHAEL H Director |
STOCK | 5.63K | $0 | Direct |
| Jul 15, 26 | ELLIS GARY LEE Director |
STOCK | 581 | $0 | Direct |
| Jul 15, 26 | MELENIKIOTOU GEORGIA Director |
STOCK | 344 | $0 | Direct |
| Jul 15, 26 | TANSEY CASEY M Director |
STOCK | 346 | $0 | Direct |
| Jul 15, 26 | BROADER SHELLEY G Director |
STOCK | 383 | $0 | Direct |
| May 15, 26 | RONDONI JOHN Officer |
SELL | 2.64K | $114.30K | Direct |
| May 14, 26 | RONDONI JOHN Officer |
SELL | 700 | $30.11K | Direct |
| May 8, 26 | MCCORMICK SHAWN T Director |
SELL | 696 | $31.54K | Direct |
| Apr 30, 26 | ELLIS GARY LEE Director |
STOCK | 3.56K | $0 | Direct |
| Apr 30, 26 | MCCORMICK SHAWN T Director |
STOCK | 3.56K | $0 | Direct |
| Apr 30, 26 | CURET MYRIAM MCADAMS Director |
STOCK | 3.56K | $0 | Direct |
| Apr 30, 26 | MELENIKIOTOU GEORGIA Director |
STOCK | 3.56K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BUCHHOLZ RICHARD |
Chief Financial Officer | 50.77K | Sale |
HERBERT TIMOTHY P |
Chief Executive Officer | 163.49K | Stock Award(Grant) |
KELLY JASON P |
Officer | 18.98K | Sale |
MANN MELISSA |
Officer | 23.61K | Stock Award(Grant) |
MCCORMICK SHAWN T |
Director | 30.71K | Sale |
MEAD DANA G JR |
Director | 26.21K | Stock Award(Grant) |
PHILLIPS BRYAN K |
General Counsel | 38.51K | Stock Award(Grant) |
RONDONI JOHN |
Officer | 27.16K | Sale |
TANSEY CASEY M |
Director | 27.63K | Stock Award(Grant) |
WEATHERBY CARLTON |
Officer | 41.68K | Stock Award(Grant) |
Fundamentals
Market cap$1.97B
Enterprise value$1.68B
Revenue (TTM)$898.74M
Gross profit$774.11M
EBITDA$71.33M
Net income$135.04M
EPS (TTM)$4.54
Free cash flow$94.64M
Total cash$320.68M
Total debt$29.09M
Book value / share$28.56
Shares outstanding28.91M
Float23.28M
Short % of float17.79%
Dividend yield0.00%
Beta (5Y)0.73
Valuation & profitability ratios
Trailing P/E15.02
Forward P/E44.09
PEG ratio—
Price / sales—
Price / book2.39
EV / revenue1.87
EV / EBITDA23.55
Gross margin86.13%
Operating margin-0.26%
Profit margin15.03%
Return on equity17.97%
Return on assets3.91%
Debt / equity3.52
Current ratio8.55
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $911.98M | $802.80M | $624.80M | $407.86M | +13.6% |
| Operating revenue | $911.98M | $802.80M | $624.80M | $407.86M | +13.6% |
| Cost of revenue | $133.22M | $122.99M | $96.58M | $66.11M | +8.3% |
| Gross profit | $778.76M | $679.82M | $528.22M | $341.74M | +14.6% |
| Research & development | $103.17M | $114.13M | $116.54M | $68.64M | -9.6% |
| Selling, general & admin | $624.64M | $529.61M | $451.96M | $320.69M | +17.9% |
| Total operating expense | $727.80M | $643.74M | $568.49M | $389.33M | +13.1% |
| Operating income | $50.95M | $36.08M | -$40.27M | -$47.59M | +41.2% |
| Net interest income | $17.40M | $23.23M | $20.56M | $3.37M | -25.1% |
| Pre-tax income | $65.70M | $58.45M | -$19.91M | -$44.27M | +12.4% |
| Tax provision | -$79.72M | $4.94M | $1.25M | $613.00K | -1,712.6% |
| Net income | $145.42M | $53.51M | -$21.15M | -$44.88M | +171.8% |
| Net income to common | $145.42M | $53.51M | -$21.15M | -$44.88M | +171.8% |
| Basic EPS | 4.95 | 1.80 | -0.72 | -1.60 | +175.0% |
| Diluted EPS | 4.89 | 1.75 | -0.72 | -1.60 | +179.4% |
| EBIT | $65.83M | $58.48M | -$19.91M | -$42.59M | +12.6% |
| EBITDA | $79.79M | $65.03M | -$17.06M | -$40.73M | +22.7% |
| Basic shares | 29.37M | 29.76M | 29.30M | 28.07M | -1.3% |
| Diluted shares | 29.76M | 29.76M | 29.30M | 28.07M | -0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $104.81M | $150.15M | $185.54M | $441.59M | — | -30.2% |
| Cash & short-term investments | $308.27M | $445.55M | $460.38M | $451.41M | — | -30.8% |
| Accounts receivable | $119.69M | $93.07M | $89.88M | $61.23M | — | +28.6% |
| Inventory | $145.29M | $80.12M | $33.88M | $11.89M | — | +81.3% |
| Total current assets | $583.65M | $630.81M | $593.74M | $530.03M | — | -7.5% |
| Property, plant & equipment | $121.40M | $95.24M | $62.65M | $24.13M | — | +27.5% |
| Total assets | $907.32M | $808.38M | $676.81M | $564.88M | — | +12.2% |
| Total current liabilities | $96.06M | $88.50M | $78.11M | $61.19M | — | +8.5% |
| Current debt | — | — | — | — | $9.19M | — |
| Long-term debt | — | — | — | — | $15.80M | — |
| Total debt | $32.16M | $31.79M | $24.85M | $8.87M | — | +1.1% |
| Total liabilities | $126.16M | $118.69M | $104.30M | $68.87M | — | +6.3% |
| Retained earnings | -$146.49M | -$291.91M | -$345.42M | -$324.27M | — | +49.8% |
| Shareholder equity | $781.16M | $689.70M | $572.51M | $496.01M | — | +13.3% |
| Working capital | $487.60M | $542.30M | $515.63M | $468.85M | — | -10.1% |
| Net tangible assets | $781.16M | $689.70M | $572.51M | $496.01M | — | +13.3% |
| Shares issued | 28.58M | 29.74M | 29.56M | 29.01M | — | -3.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $145.42M | $53.51M | -$21.15M | -$44.88M | +171.8% |
| Depreciation & amortisation | $13.96M | $6.55M | $2.85M | $1.86M | +113.1% |
| Stock-based compensation | $130.26M | $116.01M | $82.47M | $51.97M | +12.3% |
| Change in working capital | -$87.38M | -$37.71M | -$40.78M | $1.81M | -131.7% |
| Operating cash flow | $116.98M | $130.25M | $24.65M | $11.57M | -10.2% |
| Capital expenditure | -$38.50M | -$39.12M | -$23.63M | -$9.10M | +1.6% |
| Investing cash flow | $21.45M | -$113.12M | -$294.82M | -$19.60M | +119.0% |
| Share buybacks | -$175.02M | -$75.00M | $0 | $0 | -133.4% |
| Financing cash flow | -$183.45M | -$52.39M | $13.95M | $235.08M | -250.1% |
| Free cash flow | $78.48M | $91.12M | $1.02M | $2.47M | -13.9% |
| End cash position | $104.81M | $150.15M | $185.54M | $441.59M | -30.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $200.58M | $204.58M | $269.08M | $224.50M | $217.09M | -2.0% |
| Operating revenue | $200.58M | $204.58M | $269.08M | $224.50M | $217.09M | -2.0% |
| Cost of revenue | $29.12M | $27.67M | $36.07M | $31.77M | $34.67M | +5.2% |
| Gross profit | $171.46M | $176.91M | $233.01M | $192.73M | $182.41M | -3.1% |
| Research & development | $24.70M | $25.83M | $24.94M | $24.21M | $26.21M | -4.4% |
| Selling, general & admin | $147.28M | $152.20M | $161.95M | $158.87M | $159.52M | -3.2% |
| Total operating expense | $171.97M | $178.03M | $186.90M | $183.08M | $185.73M | -3.4% |
| Operating income | -$514.00K | -$1.12M | $46.11M | $9.64M | -$3.32M | +54.0% |
| Net interest income | $3.74M | $3.74M | $3.88M | $3.97M | $4.48M | -0.1% |
| Pre-tax income | $3.12M | $2.40M | $50.32M | $13.55M | -$2.33M | +30.0% |
| Tax provision | $2.80M | $13.69M | -$85.77M | $3.62M | $1.26M | -79.5% |
| Net income | $314.00K | -$11.29M | $136.09M | $9.93M | -$3.59M | +102.8% |
| Net income to common | $314.00K | -$11.29M | $136.09M | $9.93M | -$3.59M | +102.8% |
| Basic EPS | 0.01 | -0.39 | 4.70 | 0.34 | -0.12 | +102.6% |
| Diluted EPS | 0.01 | -0.39 | 4.66 | 0.34 | -0.12 | +102.6% |
| EBIT | -$514.00K | -$1.12M | $50.44M | $13.56M | -$3.32M | +54.0% |
| EBITDA | $4.08M | $3.99M | $54.26M | $17.24M | $98.00K | +2.3% |
| Basic shares | 28.84M | 28.70M | 28.94M | 29.33M | 29.51M | +0.5% |
| Diluted shares | 28.94M | 28.70M | 29.22M | 29.60M | 29.51M | +0.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $127.76M | $98.93M | $104.81M | $112.84M | $106.93M | +29.1% |
| Cash & short-term investments | $320.68M | $283.83M | $308.27M | $322.59M | $300.89M | +13.0% |
| Accounts receivable | $103.34M | $105.09M | $119.69M | $107.99M | $137.69M | -1.7% |
| Inventory | $170.45M | $166.24M | $145.29M | $141.78M | $121.63M | +2.5% |
| Total current assets | $608.67M | $566.82M | $583.65M | $586.49M | $573.19M | +7.4% |
| Property, plant & equipment | $126.93M | $123.76M | $121.40M | $115.58M | $109.80M | +2.6% |
| Total assets | $925.99M | $911.38M | $907.32M | $807.72M | $802.19M | +1.6% |
| Total current liabilities | $71.18M | $89.42M | $96.06M | $110.84M | $93.36M | -20.4% |
| Total debt | $29.09M | $29.55M | $32.16M | $32.58M | $33.06M | -1.6% |
| Total liabilities | $100.41M | $119.04M | $126.16M | $141.26M | $124.38M | -15.6% |
| Retained earnings | -$157.47M | -$157.79M | -$146.49M | -$282.58M | -$292.51M | +0.2% |
| Shareholder equity | $825.58M | $792.34M | $781.16M | $666.46M | $677.81M | +4.2% |
| Working capital | $537.49M | $477.40M | $487.60M | $475.65M | $479.83M | +12.6% |
| Net tangible assets | $825.58M | $792.34M | $781.16M | $666.46M | $677.81M | +4.2% |
| Shares issued | 28.91M | 28.80M | 28.58M | 29.05M | 29.57M | +0.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $314.00K | -$11.29M | $136.09M | $9.93M | -$3.59M | +102.8% |
| Depreciation & amortisation | $4.60M | $5.11M | $3.82M | $3.68M | $3.41M | -10.0% |
| Stock-based compensation | $31.23M | $30.69M | $28.01M | $29.47M | $41.72M | +1.7% |
| Change in working capital | -$22.83M | -$13.11M | -$26.85M | $25.44M | -$42.56M | -74.2% |
| Operating cash flow | $23.23M | $12.85M | $52.47M | $68.53M | $2.68M | +80.8% |
| Capital expenditure | -$9.16M | -$9.73M | -$10.66M | -$10.44M | -$9.00M | +5.8% |
| Investing cash flow | $3.55M | -$11.25M | -$11.92M | -$11.64M | $46.56M | +131.5% |
| Share buybacks | $0 | $0 | -$50.01M | -$50.00M | $0 | — |
| Financing cash flow | $1.91M | -$7.48M | -$48.31M | -$51.08M | $3.70M | +125.5% |
| Free cash flow | $14.07M | $3.12M | $41.81M | $58.09M | -$6.31M | +350.5% |
| End cash position | $127.76M | $98.93M | $104.81M | $112.84M | $106.93M | +29.1% |
Options analytics
Put / call volume
0.03
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
35.00
-48.7% from spot
ATM implied vol
3.1%
Nearest strike to spot
Skew (10% OTM)
+12.5%
Puts bid over calls
Call volume
1.16K
Contracts, this expiry
Put volume
35
Contracts, this expiry
Heaviest call OI
50.00
0 contracts
Heaviest put OI
35.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.25 | 0.14 | +157.1% |
| Mar 2026 | -0.26 | 0.10 | +138.4% |
| Dec 2025 | 0.68 | 1.65 | +142.1% |
| Sep 2025 | -0.17 | 0.38 | +323.6% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.09 | 13 | $204.32M | -9.0% |
| Next quarter | 0.91 | 13 | $244.37M | -9.2% |
| Current year | 1.25 | 13 | $853.86M | -6.4% |
| Next year | 1.55 | 14 | $887.21M | +3.9% |
Analyst targets & ownership
Mean target$65.00
High target$97.00
Low target$40.00
Implied upside-4.69%
Analyst count15
ConsensusHOLD
Strong buy / Buy0 / 4
Hold11
Sell / Strong sell1 / 1
Held by insiders1.18%
Held by institutions130.19%
Institutions holding385
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
70.06
-2.66% from price
SMA 20
71.32
-4.38% from price
SMA 50
63.98
+6.59% from price
SMA 100
54.60
+24.90% from price
SMA 200
60.84
+12.09% from price
EMA 12
70.20
-2.85% from price
EMA 26
68.52
-0.47% from price
EMA 50
64.59
+5.59% from price
RSI (14)
49.7
Neutral
MACD (12,26,9)
1.68
Hist -0.83
ATR (14)
3.74
5.48% of price
Realised vol 30D
49.2%
Annualised
Bollinger upper
76.66
20, 2σ
Bollinger lower
65.98
20, 2σ
50 / 200 cross
Golden
63.98 vs 60.84
Trend bias
Above 200
+12.09%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.05
More volatile than market
Correlation to SPY
0.19
Largely independent
Realised vol 30D
49.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-72.2%
Peak to trough
Max drawdown 5Y
-87.7%
Peak to trough
ATR 14
3.74
5.48% of price
Beta (reported)
0.73
5Y monthly, from filing
Short interest
Shares short
3.93M
Prior 4.37M
Change vs prior
-10.2%
Shorts covering
% of float
17.79%
Elevated
% of shares out
13.59%
Against total outstanding
Days to cover
6.2
Crowded exit
Float
23.28M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 2, 26 | Freedom Capital Markets | MAINTAINED | Buy | Buy |
| Oct 1, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Sep 21, 26 | Freedom Capital Markets | MAINTAINED | Buy | Buy |
| Sep 11, 26 | Stifel | MAINTAINED | Buy | Buy |
| Aug 4, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Aug 4, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Aug 4, 26 | Oppenheimer | UPGRADE | Perform | Outperform |
| Aug 4, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Aug 4, 26 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Aug 4, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Aug 4, 26 | Baird | MAINTAINED | Neutral | Neutral |
| Jul 16, 26 | Truist Securities | MAINTAINED | Hold | Hold |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-03
Corporate Changes & Voting Matters
8-K · 2026-07-24
Corporate Changes & Voting Matters
8-K · 2026-07-22
Corporate Changes & Voting Matters
8-K · 2026-06-26
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-06-01
Offering Registrations
S-8 · 2026-05-07
Corporate Changes & Voting Matters
8-K · 2026-05-05
Corporate Changes & Voting Matters
8-K · 2026-05-04
Headlines
1 Profitable Stock Worth Your Attention and 2 We Ignore
StockStory · 20h ago
Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
GlobeNewswire · 1d ago
How Investors Are Reacting To Inspire Medical Systems (INSP) Securing Category I CPT Codes For Inspire V
Simply Wall St. · 2d ago
Medical Devices & Supplies - Specialty Stocks Q2 Earnings Review: Inspire Medical Systems (NYSE:INSP) Shines
StockStory · 2d ago
Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation
Zacks · 2d ago
Inspire Medical (INSP): How Much Optimism Is Baked Into This Medtech Stock?
Insider Monkey · 3d ago
Inspire Medical Systems Gets New CPT Codes for Hypoglossal Nerve Stimulation
MT Newswires · 5d ago
Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
GlobeNewswire · 5d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.